Violaine Ozenne

Summary

Country: France

Publications

  1. doi request reprint Liver tumours in patients with Fanconi anaemia: a report of three cases
    Violaine Ozenne
    Department of Hepatology, Hopital Beaujon, APHP, Clichy, France
    Eur J Gastroenterol Hepatol 20:1036-9. 2008
  2. doi request reprint Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
    Violaine Ozenne
    Departments of Hepatology, Hopital Beaujon, Clichy, AP HP, France
    Eur J Gastroenterol Hepatol 22:1106-10. 2010
  3. ncbi request reprint Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report
    Violaine Ozenne
    Service d Hepatologie, Hopital Beaujon, APHP, Clichy, France
    Hepatogastroenterology 58:161-2. 2011
  4. doi request reprint Prospective evaluation of the management of hepatocellular carcinoma in the elderly
    Violaine Ozenne
    Department of Hepatology, Hopital Beaujon, AP HP, Clichy, France
    Dig Liver Dis 43:1001-5. 2011
  5. doi request reprint Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy
    Thomas Sersté
    Assistance Publique Hopitaux de Paris, APHP Service d Hépatologie, Hopital Beaujon, Clichy, France
    Hepatology 55:800-6. 2012
  6. doi request reprint Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome
    Pierre Emmanuel Rautou
    Pôle des Maladies de l Appareil Digestif, Service d Hepatologie, Hopital Beaujon, AP HP, Clichy, France
    Clin Gastroenterol Hepatol 7:1230-5. 2009

Detail Information

Publications6

  1. doi request reprint Liver tumours in patients with Fanconi anaemia: a report of three cases
    Violaine Ozenne
    Department of Hepatology, Hopital Beaujon, APHP, Clichy, France
    Eur J Gastroenterol Hepatol 20:1036-9. 2008
    ..With prolongation of survival, continued development of liver tumours can be expected. Routine detection should therefore be considered in these patients as curative resection can be performed...
  2. doi request reprint Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
    Violaine Ozenne
    Departments of Hepatology, Hopital Beaujon, Clichy, AP HP, France
    Eur J Gastroenterol Hepatol 22:1106-10. 2010
    ..The aims of this study were (i) to evaluate the tolerance and survival of sorafenib-treated patients, in a nonselected population, especially in Child-Pugh B patients; and (ii) to identify potential prognostic factors of survival...
  3. ncbi request reprint Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report
    Violaine Ozenne
    Service d Hepatologie, Hopital Beaujon, APHP, Clichy, France
    Hepatogastroenterology 58:161-2. 2011
    ..Interactions between sorafenib and highly active antiretroviral therapy (HAART) have not been studied yet. We report a case of serious adverse effects in anHIV-1 patient co-infected with HBV...
  4. doi request reprint Prospective evaluation of the management of hepatocellular carcinoma in the elderly
    Violaine Ozenne
    Department of Hepatology, Hopital Beaujon, AP HP, Clichy, France
    Dig Liver Dis 43:1001-5. 2011
    ..Previous studies suggested that ageing does not adversely impact survival but they have the drawback of being retrospective and spanning a prolonged period of time...
  5. doi request reprint Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy
    Thomas Sersté
    Assistance Publique Hopitaux de Paris, APHP Service d Hépatologie, Hopital Beaujon, Clichy, France
    Hepatology 55:800-6. 2012
    ..There was a disagreement regarding imaging findings between CT and MRI in 21 of 74 (28%) patients and no washout on both examinations in 23 of 74 patients (31%). In these 44 patients, liver biopsy provided an initial accurate diagnosis...
  6. doi request reprint Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome
    Pierre Emmanuel Rautou
    Pôle des Maladies de l Appareil Digestif, Service d Hepatologie, Hopital Beaujon, AP HP, Clichy, France
    Clin Gastroenterol Hepatol 7:1230-5. 2009
    ..An increased level of serum alanine aminotransferase (ALT) is an objective marker for acute liver injury. We analyzed the significance of changes in ALT levels in Budd-Chiari syndrome patients...